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ABSTRACT
Aspergillus Genomes is a public resource for
viewing annotated genes predicted by various
Aspergillus sequencing projects. It has arisen
from the union of two significant resources: the
Aspergillus/Aspergillosis website and the Central
Aspergillus Data REpository (CADRE). The former
has primarily served the medical community, provid-
ing information about Aspergillus and associated
diseases to medics, patients and scientists; the
latter has focused on the fungal genomic commu-
nity, providing a central repository for sequences
and annotation extracted from Aspergillus
Genomes. By merging these databases, genomes
benefit from extensive cross-linking with medical
information to create a unique resource, spanning
genomics and clinical aspects of the genus.
Aspergillus Genomes is accessible from http://
www.aspergillus-genomes.org.uk.
INTRODUCTION
An important consequence of the impact of global climate
change, brought to the fore by recent natural disasters, has
been a stimulation of interest in fungal ecology. In the
aftermath of Hurricanes Katrina and Rita, for example,
residential areas in New Orleans, having remained under-
water for weeks, succumbed to rapid mould growth (1–3),
facing residents with signiﬁcant health hazards: exposure
to high concentrations of some moulds (e.g. Aspergillus,
Cladosporium and Trichoderma) can cause severe and
sometimes life-threatening responses. Examination of
samples taken from aﬀected homes identiﬁed several
Aspergillus species, Aspergillus niger being predominant
amongst them. The concentration of this and other species
reached levels generally associated with environmental
health problems. The paucity of eﬀective drugs available
to treat Aspergillus infections, coupled with the speed of
diagnosis required for successful treatment, raises con-
cerns for residents and tradesmen who return to restore
such areas without taking appropriate protective
measures.
Generally, Aspergillus is a genus of fungus found world-
wide: approximately 250 species descriptions have been
published (4,5), several of which are of medical or indus-
trial importance. Aspergillus fumigatus is the most
common mould pathogen of humans, causing both life-
threatening invasive disease of immuno-compromised
patients and allergic disease in patients with atopic
immune systems (6–8). Aspergillus nidulans, an occasional
human pathogen, is a model organism that has contrib-
uted to our understanding of genetics, gene regulation and
cellular biology (9,10), while A. niger (11,12) and A. oryzae
(13) are both used in industrial processes. Aspergillus ﬂavus
is both a human and plant pathogen, being responsible for
a disproportionate number of cutaneous and wound infec-
tions in man (14). Several other Aspergillus species are
known to be signiﬁcant allergens or to be responsible for
mycotoxin production in stored food (15–17).
In light of their relevance to medicine and industry, and
the desire to better understand this genus, the genomes of
10 Aspergilli have recently been sequenced, seven of which
have been annotated in worldwide collaborative eﬀorts.
To be of maximum beneﬁt to the community in general,
this expanding pool of genomic data (the volume of which
is likely to increase with the decreasing cost of sequencing)
requires collation and long-term maintenance; more par-
ticularly, to beneﬁt research into Aspergillosis and other
illnesses caused by this genus, the accumulating genomic
data needs to be cross-linked to the numerous Aspergillus-
related medical reports now available. However, the stan-
dard model for genome databases [e.g. SGD (18)] is not
appropriate for medically signiﬁcant organisms, where the
dissemination of information, such as patient care, drug
resistance or toxins is equally important. Thus, Aspergil-
lus Genomes was established in April 2008 to provide
links between genomic and medical information and to
provide access through one portal.
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This resource is a joint undertaking by two teams that
have, until now, provided online medical and genomic
information for diﬀerent groups within the Aspergillus
community.
Medicalinformation
The Aspergillus/Aspergillosis website (http://www.asper
gillus.org.uk) was designed to serve the medical and trans-
lational research communities, including medical consul-
tants, scientists, patients and their relatives. Oﬀering
a wealth of information about Aspergillus and the multiple
diseases (known collectively as Aspergillosis) it can cause,
one section provides advice and a discussion group for
patients, while other areas provide medical and species
images, educational materials, meeting reports and publi-
cations. As part of Aspergillus Genomes, this large collec-
tion of material oﬀers a valuable repository from which we
can begin to derive much-needed medical insights from
genome analyses (Some sections require registration,
please refer to supplement ‘Note: Access information’).
Genomic information
The Central Aspergillus Data REpository, CADRE
(http://www.cadre-genomes.org.uk) (19), was developed
primarily to serve the Aspergillus genomics community.
Its principal role has been to manage genomic data and
to oﬀer web-based tools for analysis and visualization of
genomic features. These tools oﬀer simple displays for
viewing annotation of predicted genes (e.g. function, GO
terms, similarity matches) and of their protein products
(e.g. family and domain similarity matches), as well as
complex displays for viewing genes and other features
(e.g. RNA-encoding genes, repeated sequences) in the con-
text of an assembly.
Incorporation of this resource into Aspergillus
Genomes provides access to seven annotated genomes,
ﬁve of which are of particular importance to the Aspergil-
lus genetics community (A. fumigatus Af293 and A1163,
A. nidulans, A. oryzae and A. niger); of these, two are
clinical isolates (A. fumigatus Af293 and A1163).
CONTENT OF CURRENT RELEASE
Aspergillus Genomes has been implemented using
Ensembl version 22 (20), a suite devised for storing anno-
tated eukaryotic genomes. The latest release (June 2008)
contains information pertaining to seven genomes.
Aspergillus fumigatus(Af293) 2.2.1
Using whole-genome shotgun (WGS) sequencing (carried
out by TIGR) and optical mapping, this project yielded
an assembly of 19 supercontigs (28.8Mb) mapping
onto eight chromosomes. Using automated gene predic-
tions, the University of Manchester coordinated an inter-
national manual annotation project, and data for 9926
genes were released in 2005 (21). This genome has since
been re-annotated as part of an additional international
comparative project led by the J. Craig Venter Institute
(JCVI) and the University of Manchester. Data for 9630
predicted protein-coding genes were publicly released
in 2008 (22).
Aspergillus nidulans(FGSC A4) 5.3.1
WGS sequencing of this genome was undertaken by the
Broad Institute and publicly released in March 2003. This
project yielded an assembly of 17 supercontigs (30Mb)
assigned to eight linkage groups, a group of unassigned
fragments (84 contigs) and 9520 predicted protein-coding
genes. Further automated and manual annotation carried
out by TIGR (2005) yielded a total of 10542 genes (23)—
using publicly available linkage data (John Clutterbuck,
http://www.gla.ac.uk/ibls/molgen/aspergillus/index.html)
and in-house analyses, we have updated the original
Broad assembly to reﬂect these ﬁndings. More contigs
have now been mapped, with correct orientation, within
each supercontig; the supercontigs have also been orien-
tated correctly within each linkage group.
Aspergillus oryzae (RIB 40) 1.1.1
WGS sequencing of this genome was undertaken by a
Japanese Consortium, led by the National Institute of
Advanced Industrial Science and Technology (AIST).
Using optical mapping, the project yielded an assembly
of 22 supercontigs (37.1Mb) mapped to eight chromo-
somes and a group of unassigned fragments. Using auto-
mated annotation techniques, 12 074 protein-coding genes
were predicted and publicly released in 2005 (24).
Aspergillus niger (CIB 513.88) 1.1.1
Using WGS sequencing and BAC walking (carried out by
DSM Food Specialties), this project yielded 19 supercon-
tigs (33.9Mb) mapping onto eight chromosomes. Using
a base of automated gene predictions, DSM coordinated a
European manual annotation project, predicting 14086
protein-coding genes, and data were released in 2007 (25).
Aspergillus fumigatus (A1163) 1.1.1,A. clavatus (NRRL 1)
1.1.1 and Neosartoryafischeri (NRRL 181) 1.1.1
These genomes were sequenced using WGS sequencing
(carried out by JCVI), as part of an international com-
parative project led by JCVI and the University of
Manchester (2008) (22). The work on A. fumigatus yielded
55 scaﬀolds (29Mb), for which 9929 protein-coding
genes were predicted; A. clavatus yielded 143 unassigned
fragments (27.8Mb), for which 9121 protein-coding
genes were automatically predicted; and N. ﬁscheri yielded
976 unassigned fragments (32.5Mb), for which 10406
protein-coding genes were automatically predicted.
DISPLAY AND SEARCH SOFTWARE
Several tools are provided (via CADRE) for viewing geno-
mic data within Aspergillus Genomes. GeneView (Supple-
mentary Figure S1) is the principal data-visualization tool,
oﬀering detailed information about a particular gene,
including the public locus, the chromosomal location
and a short description of the gene. An overview of each
predicted transcript is also provided: this consists of
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to similar sequences (e.g. SGD) and protein features [e.g.
InterPro (26)], and GO terms that have been mapped to
the gene. Images are also displayed of each transcript
structure and of domains or family signatures mapped
to the protein.
In addition to the information provided in GeneView,
Transview provides the transcript sequence, which can be
marked up to highlight both codons and the peptide
sequence. ExonView provides the nucleotide sequence
for each exon, as well as the upstream and downstream
regions, untranslated regions and introns. ProtView dis-
plays further information about a particular protein and,
in addition to the GeneView summary it provides the
sequence in FASTA format, which can be marked up to
highlight exons. ProtView also provides some predicted
peptide statistics and information about any matches to
family- or domain-based databases [e.g. Pfam (27),
PRINTS (28)].
Four search tools, all accessible from the homepage, are
available for Aspergillus Genomes: UniSearch, Google
TM
customized search, the Aspergillus Cloud and BLAST.
UniSearch, the in-built Ensembl search tool, allows users
to search public identiﬁers assigned to genes (e.g.
AFUB_063690 and An14g07380)—it is found on the
homepage and throughout the website. A familiar tool is
provided in the form of a customized Google
TM search
engine, thus enabling free-text searches on all information
pages and genomes within the resource. A more recent
addition is ‘cloud’ searching, which is described in more
detail below. To allow similarity searches, BLAST can be
performed against in-house sequences (i.e. genomic
sequence, predicted ORFs and proteins), the results of
which are presented in the context of the assembly
rather than as stand-alone alignments.
THE ASPERGILLUS CLOUD
The results of UniSearch or Google
TM searches are pro-
vided in the form of lists of pages and documents match-
ing the given term. Although useful in many cases, this
type of output does not empower the user to access and
search related data. To remedy this, we have introduced
the Aspergillus Cloud, a facility that uses ‘cloud’ searching
(developed by Quintura
TM) across the medical and geno-
mic information embraced by Aspergillus Genomes.
Cloud searching provides a visual means of searching
related terms: when a search term is entered, this generates
a group (or cloud) of related terms from context, as well as
a list of hyperlinks to relevant pages/documents.
Furthermore, by exploring the cloud (i.e. by moving a
mouse over any term), search results change to reﬂect
relationships with the new highlighted term.
We can demonstrate the Aspergillus Cloud using docu-
mented research on point mutations in the cyp51a gene
and its correlation to rising triazole drug resistance. By
simply entering ‘cyp51a’ into the search box (Figure 1),
a number of related terms are displayed, as well as a
number of hyperlinks to relevant pages. Several links pro-
vide access to pages that are contained within the medical
section of Aspergillus Genomes and refer to point muta-
tions within the gene and drug resistance; one provides
access to the relevant gene within the genomic section of
Aspergillus Genomes. Medical terms can also be used to
explore the Aspergillus Cloud (Figure 2). By entering the
term ‘Allergic Bronchopulmonary Aspergillosis’ (ABPA;
an allergic reaction to Aspergillus spores), opportunities
are given to explore articles written about the allergen to
which ABPA patients are hypersensitive, as well as anno-
tation provided for an ABPA-related gene.
The Aspergillus Cloud provides a powerful means of
exploring Aspergillus data and ﬁnding medical reports
linked to particular genes that would require several
search attempts or would otherwise be missed using con-
ventional search tools.
EXPLORING FEATURES OF INTEREST
The collation of Aspergillus data enables us to focus on
and embellish features of medical interest. Aspergillus
fumigatus, for example, possesses over 80 genes encoding
allergen proteins and of these 22 have been cloned as IgE
binding (29,30). We have documented these allergens
within Aspergillus Genomes and provided links to anno-
tated genes (http://www.aspergillus.org.uk/indexhome.
htm?secure/sequence_info/genesoﬁnterest/allergens.php).
Another area of great interest is secondary metabolites.
We have already extracted information on many second-
ary metabolites (http://www.aspergillus.org.uk/secure/
metabolites/list_by_secmet.php) and intend to link this
data to annotated genes. We also have begun the process
of highlighting secondary metabolite clusters, such as the
gliotoxin biosynthestic cluster. Gliotoxin is a toxin pro-
duced by A. fumigatus and possesses many biological
properties, including the ability to act as an antibacterial
and antiviral agent as well as an immunosuppressant
(31,32). We have provided a view of the gene cluster
within the assembly and links to the appropriate annota-
tion (Figure 3).
FUTURE DIRECTIONS
In the short term, we plan to add three more new genomes
and to revise a fourth. The new genomes include A. ﬂavus
NRRL 3357 (TIGR, 2005), A. terreus (Broad Institute,
2006) and A. niger ATCC 1015 (DOE Joint Genome
Institute, 2006): although these genomes have been
sequenced with high coverage, only draft sequence and
limited annotation are currently publicly available—we
will add the sequence data to our collection for compara-
tive work and add annotation as it becomes available.
As for the latter, we are currently participating in Euro-
fungbase, a European project coordinated by Eurofung
(http://www.eurofung.net), to manually re-annotate
A. nidulans with the help of experts from 32 laboratories
and 13 industrial partners. Our role is to house the cor-
rected gene structures and annotation arising from this
project, and to make the data publicly available: we are
processing this information in-house, and will release it
through CADRE and Aspergillus Genomes.
Nucleic Acids Research, 2009,Vol. 37,Database issue D511Figure 2. Using the Aspergillus Cloud to explore medical information. Entering a medical condition, such as ABPA, into the search box (a),
produces several groups of related terms within the search space below. By moving the mouse over each term, new clouds arise temporarily.
Clicking on a term will add the associated clouds into the search space and change the focus of the search to include the term (b). In this example,
we ﬁnd a list of documents on the RHS that includes links to an ABPA-related gene (c) and to an article regarding an allergen that is particular to
the allergic response of ABPA patients (d).
Figure 1. Using the Aspergillus Cloud to explore genes. Entering a gene name, such as ‘cyp51a’, into the search box at the top of the cloud search
space (a) produces numerous related search terms immediately below and a list of relevant documents/records at the RHS. The document list
provides an extract for each document enabling the user to assess the context of the search term found. By clicking on relevant links, the user can
access both medical reports (b) and genomic annotation (c) for a given gene name.
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tion dealing with areas of medical interest. Explicit links
and clustering of such data enables rapid assimilation of
essential information. In addition, to support in-house
work and provide users with value-added data, we will
expand our comparative analyses and include resultant
data within Aspergillus Genomes. Access to similar data
is currently facilitated by the Broad Aspergillus Compara-
tive Database (http://www.broad.mit.edu/annotation/gen
ome/aspergillus_group/MultiHome.html); however, in
contrast with Aspergillus Genomes, which places much
attention on the underlying data, the Broad site focuses
on function. By providing up-to-date primary data, we
hope to yield consistent secondary data, as well as relevant
links to current medical information.
CONCLUSIONS
The Aspergilli garner interest owing to their medical and
industrial signiﬁcance, but changes in the environment
are making the interest in this genus and its eﬀects on
the human condition more prominent. It is therefore
timely to begin the process of marrying medical and
genomic information. By maintaining a resource that
accommodates both such data types, and by providing
several means of viewing, searching and analysing the
data, we hope to better serve the Aspergillus research
community.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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